AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders. (2019)

First Author: Salpietro V

Attributed to: Gene therapy for refractory epilepsy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-10910-w

PubMed Identifier: 31300657

Publication URI: http://europepmc.org/abstract/MED/31300657

Type: Journal Article/Review

Volume: 10

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723